Dec 14, 2022 / 01:00PM GMT
Operator
Good morning, and welcome to the Calliditas Therapeutics Fireside Chat. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Calliditas website following the conclusion of the event.
I'd now like to turn the call over to Renee Lucander, Chief Executive Officer of Calliditas Therapeutics. Please go ahead, Renee.
Renee Aguiar-Lucander - Calliditas Therapeutics AB(publ)-CEO
Thank you very much, and welcome, everybody, to this fireside chat. So with me today I have some of our -- from our partner Everest Medicines. So the people joining us here on the call is Rogers Luo who's CEO of Everest Medicines; we have Dr. Zhengying Zhu who is CMO; and we have Ian Woo who is President and CFO of Everest Medicines. The Q&A is going to be managed by Ashley Robinson from LifeSci when we get to that section.
So first of all, I just want to give you a very brief, because I know you haven't come to this to listen to me talk about Calliditas, but I'm
Calliditas Therapeutics AB Fireside Chat with Everest Medicines Ltd Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot